0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight xiliarx api insights 2014.Your search for "" gave back 938153 results.
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability and stability of active...
Catalog:
IQ4I
September 2016
Price: USD 4,500.00
The leading vendors in the cloud data center market have invested in high-quality technology and processes to develop leading edge systems...
Catalog:
WinterGreen Research
June 2019
Price: USD 4,400.00
Global antirheumatics market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical...
Catalog:
NAVADHI
June 2019
Price: USD 2,000.00
Global oncology market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions and...
Catalog:
NAVADHI
May 2019
Price: USD 2,000.00
Information services will leverage automated process to leverage cloud computing: services The value of sports analytics is the predictive...
Catalog:
WinterGreen Research
May 2015
Price: USD 4,000.00
Global antidiabetics pharmaceutical market is expected to grow in near future as aging and growing population, rising income levels, and emerging...
Catalog:
NAVADHI
June 2019
Price: USD 2,000.00
The report has 815 pages, 259 tables and figures . Worldwide markets are poised to achieve significant growth as the push to talk is used inside...
Catalog:
WinterGreen Research
April 2015
Price: USD 4,000.00
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Favipiravir market size was valued at US$ 335.3 million in 2023. With growing demand in downstream market, the Favipiravir is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Favipiravir market size was valued at USD 352.7 million in 2023 and is forecast to a readjusted size of USD 67 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity Summary GBI Research’s latest report, "Pharmaceutical Deal...
CBR Pharma Insights
October 2015
Price: USD 2,995.00
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Summary Sewer Cameras market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
June 2019
Price: USD 2,960.00
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
